From: Tuberous sclerosis preclinical studies: timing of treatment, combination of a rapamycin analog (CCI-779) and interferon-gamma, and comparison of rapamycin to CCI-779
Score
Area Range (mm2)
1
0.01 < x ≤ 0.09
2
0.09 < x ≤ 0.2
3
0.2 < x ≤ 0.35
4
0.35 < x ≤ 0.5
5
x > 0.5